Smith & Nephew plc (LON:SN)

London flag London · Delayed Price · Currency is GBP · Price in GBp
1,069.00
+1.00 (0.09%)
May 9, 2025, 4:38 PM BST
7.14%
Market Cap 9.35B
Revenue (ttm) 4.64B
Net Income (ttm) 329.09M
Shares Out 875.04M
EPS (ttm) 0.38
PE Ratio 28.47
Forward PE 14.25
Dividend 0.28 (2.64%)
Ex-Dividend Date Mar 27, 2025
Volume 1,609,983
Average Volume 2,963,430
Open 1,069.00
Previous Close 1,068.00
Day's Range 1,063.50 - 1,074.00
52-Week Range 911.00 - 1,245.26
Beta 0.62
RSI 58.20
Earnings Date Jul 31, 2025

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1856
Employees 17,349
Stock Exchange London Stock Exchange
Ticker Symbol SN
Full Company Profile

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD Financial Statements

News

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

The CARTIHEAL Implant will be featured at the  Arthroscopy Association of North America Annual Meeting (AANA 2025) this week

2 days ago - GlobeNewsWire

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today anno...

4 days ago - GlobeNewsWire

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Smith & Nephew is undergoing a turnaround under CEO Deepak Nath, focusing on margin expansion and growth. See why I rate SNN stock a Buy now.

19 days ago - Seeking Alpha

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

Global financial markets are in turmoil this morning after the US President announced sweeping tariffs on several countries in a push to lower the nation's trade deficit. Trump's new tariffs are parti...

5 weeks ago - Invezz

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Sur...

2 months ago - GlobeNewsWire

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopae...

2 months ago - GlobeNewsWire

Smith & Nephew PLC (SNN) Achieves Milestone in Hip Replacement Technology

Smith & Nephew PLC (SNN) Achieves Milestone in Hip Replacement Technology

2 months ago - GuruFocus

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Regi...

2 months ago - GlobeNewsWire

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

The global wound care market size was valued at USD 23.13 billion in 2024 and is projected to reach from USD 24.04 billion in 2025 to USD 32.75 billion by 2033, growing at a CAGR of 3.94% during the f...

2 months ago - GlobeNewsWire

MARKET REPORT: Recovery hopes breathe life into hip replacement maker Smith & Nephew

Smith & Nephew shares rose 10% in early trading before ending the day up 6.1%, or 64p, to 1107.5p. That took gains for the year to nearly 11%.

2 months ago - This is Money

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Deepak Nath, CEO of Smith & Nephew discusses spin offs, navigating the China market, and the medical tech firm's full-year earnings for 2024.

2 months ago - CNBC International TV

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Deepak Nath, CEO of Smith & Nephew discusses, spin offs, navigating the China market, and the medical tech firm's full-year earnings for 2024.

2 months ago - CNBC

Hip replacement firm Smith & Nephew’s profit surges amid recovery in US sales

The medical technology giant has been in the midst of a turnaround effort, and recently faced calls from its top investors to break the company up.

2 months ago - Evening Standard

Earnings Scheduled For February 25, 2025

Companies Reporting Before The Bell • Super Group (SGHC) (NYSE: SGHC) is estimated to report earnings for its fourth quarter. • Carter's (NYSE: CRI) is expected to report quarterly earnings at $1.90...

2 months ago - Benzinga

UK Stock Market News: On The Beach, Unite Group, Smith & Nephew

On The Beach expects a strong summer, return of overseas students boosts Unite, Smith & Nephew outlook upbeat in full year results

2 months ago - The Armchair Trader

UK's Smith+Nephew beats annual profit expectations

Smith+Nephew beat analysts' expectations for annual sales and profit on Tuesday, as a recovery in its U.S. knee and hip implant business, along with cost cuts, helped the medical products maker offset...

2 months ago - Reuters

Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC

Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC

2 months ago - GuruFocus

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

First in market to o ffe r A djustable T ensioning T echnology * for i nsertional A chilles r econstruction and l ateral a nkle i nstability r epair

2 months ago - GlobeNewsWire